{"id":40891,"date":"2023-06-05T10:55:28","date_gmt":"2023-06-05T08:55:28","guid":{"rendered":"http:\/\/osaraba.eus\/infoberriak\/?p=40891"},"modified":"2023-06-05T10:55:28","modified_gmt":"2023-06-05T08:55:28","slug":"nuevo-medicamento-a-examen-romosozumab","status":"publish","type":"post","link":"https:\/\/osaraba.eus\/infoberriak\/es\/nuevo-medicamento-a-examen-romosozumab\/","title":{"rendered":"Nuevo medicamento a examen: Romosozumab"},"content":{"rendered":"<h4><img data-recalc-dims=\"1\" loading=\"lazy\" decoding=\"async\" class=\"aligncenter wp-image-40889 size-full\" src=\"https:\/\/i0.wp.com\/osaraba.eus\/infoberriak\/wp-content\/uploads\/2023\/06\/CVF.jpg?resize=775%2C367\" alt=\"\" width=\"775\" height=\"367\" srcset=\"https:\/\/i0.wp.com\/osaraba.eus\/infoberriak\/wp-content\/uploads\/2023\/06\/CVF.jpg?w=775&amp;ssl=1 775w, https:\/\/i0.wp.com\/osaraba.eus\/infoberriak\/wp-content\/uploads\/2023\/06\/CVF.jpg?resize=300%2C142&amp;ssl=1 300w, https:\/\/i0.wp.com\/osaraba.eus\/infoberriak\/wp-content\/uploads\/2023\/06\/CVF.jpg?resize=768%2C364&amp;ssl=1 768w, https:\/\/i0.wp.com\/osaraba.eus\/infoberriak\/wp-content\/uploads\/2023\/06\/CVF.jpg?resize=520%2C245&amp;ssl=1 520w, https:\/\/i0.wp.com\/osaraba.eus\/infoberriak\/wp-content\/uploads\/2023\/06\/CVF.jpg?resize=720%2C340&amp;ssl=1 720w\" sizes=\"auto, (max-width: 775px) 100vw, 775px\" \/><\/h4>\n<h4 style=\"text-align: center;\">El objetivo de las fichas \u00ab<strong>Nuevo Medicamento a Examen<\/strong>\u00bb es suministrar informaci\u00f3n objetiva, evaluada, independiente y concisa sobre los nuevos medicamentos comercializados en el Estado<\/h4>\n<p style=\"text-align: justify;\">Est\u00e1 disponible en la\u00a0<a title=\"https:\/\/www.euskadi.eus\/informacion\/medicamentos-de-atencion-primaria\/web01-a2cevime\/es\/\" href=\"https:\/\/www.euskadi.eus\/informacion\/medicamentos-de-atencion-primaria\/web01-a2cevime\/es\/\" target=\"_blank\" rel=\"noopener\" data-cke-saved-href=\"https:\/\/www.euskadi.eus\/informacion\/medicamentos-de-atencion-primaria\/web01-a2cevime\/es\/\" data-interception=\"off\">web<\/a>\u00a0la ficha \u201cNuevo Medicamento a Examen\u201d\u00a0de\u00a0Romosozumab en el tratamiento de la osteoporosis grave en mujeres posmenop\u00e1usicas con elevado riesgo de fractura, realizados por el\u00a0<b>Comit\u00e9 de Evaluaci\u00f3n de Nuevos Medicamentos de Euskadi<\/b>.<\/p>\n<p style=\"text-align: justify;\">Las evaluaciones son realizadas por el Comit\u00e9 de Evaluaci\u00f3n de Nuevos Medicamentos (CENM) de Euskadi, compuesto por un equipo de\u00a0 profesionales sanitarios del Departamento de Salud, de Osakidetza y de la Universidad del Pa\u00eds Vasco.<\/p>\n<p><a title=\"https:\/\/www.euskadi.eus\/contenidos\/informacion\/medicamentos_atencion_primaria\/es_def\/adjuntos\/CASTELLANO.pdf\" href=\"https:\/\/www.euskadi.eus\/contenidos\/informacion\/medicamentos_atencion_primaria\/es_def\/adjuntos\/CASTELLANO.pdf\" target=\"_blank\" rel=\"noopener\" data-interception=\"off\" data-cke-saved-href=\"https:\/\/www.euskadi.eus\/contenidos\/informacion\/medicamentos_atencion_primaria\/es_def\/adjuntos\/CASTELLANO.pdf\">Ficha<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>El objetivo de las fichas \u00abNuevo Medicamento a Examen\u00bb es suministrar informaci\u00f3n objetiva, evaluada, independiente y concisa sobre los nuevos medicamentos comercializados en el Estado.<\/p>\n","protected":false},"author":6,"featured_media":40889,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[958],"tags":[593],"class_list":["post-40891","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-en-portada","tag-farmacia"],"jetpack_featured_media_url":"https:\/\/i0.wp.com\/osaraba.eus\/infoberriak\/wp-content\/uploads\/2023\/06\/CVF.jpg?fit=775%2C367&ssl=1","jetpack_shortlink":"https:\/\/wp.me\/paCxCe-aDx","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/osaraba.eus\/infoberriak\/wp-json\/wp\/v2\/posts\/40891","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/osaraba.eus\/infoberriak\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/osaraba.eus\/infoberriak\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/osaraba.eus\/infoberriak\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/osaraba.eus\/infoberriak\/wp-json\/wp\/v2\/comments?post=40891"}],"version-history":[{"count":0,"href":"https:\/\/osaraba.eus\/infoberriak\/wp-json\/wp\/v2\/posts\/40891\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/osaraba.eus\/infoberriak\/wp-json\/wp\/v2\/media\/40889"}],"wp:attachment":[{"href":"https:\/\/osaraba.eus\/infoberriak\/wp-json\/wp\/v2\/media?parent=40891"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/osaraba.eus\/infoberriak\/wp-json\/wp\/v2\/categories?post=40891"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/osaraba.eus\/infoberriak\/wp-json\/wp\/v2\/tags?post=40891"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}